Mumps - Annual Epidemiological Report for 2017

Surveillance report

23 Apr 2020

Publication series: Annual Epidemiological Report on Communicable Diseases in Europe

Time period covered: This report is based on data for 2017 retrieved from The European Surveillance System (TESSy) on 31 January 2019

Cite:

ECDC’s annual surveillance reports provide a wealth of epidemiological data to support decision-making at the national level. They are mainly intended for public health professionals and policymakers involved in disease prevention and control programmes.

Download

Mumps - Annual Epidemiological Report for 2017 - EN - [PDF-815.85 KB]

Read more on the ECDC website

Prevention and control measures for mumps

Immunisation is the only effective method of prevention. Mumps vaccine is given in the form of the combined trivalent measles-mumps-rubella (MMR) vaccine in all European countries with a first dose at or before 18 months of age. The timing of the second dose varies across countries.

Facts about mumps

Mumps is a viral infection first described by Hippocrates that in its classical form causes acute parotitis and, less frequently, orchitis, meningitis and pneumonia.